{"id":"NCT00316914","sponsor":"Alliance for Clinical Trials in Oncology","briefTitle":"Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity Caused By Oxaliplatin in Patients Receiving Combination Chemotherapy for Stage II, Stage III, or Stage IV Colorectal Cancer That Has Been Completely Removed By Surgery","officialTitle":"A Phase III Randomized, Placebo-Controlled, Double-Blind Study of Intravenous Calcium/Magnesium to Prevent Oxaliplatin-Induced Sensory Neurotoxicity","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-01","primaryCompletion":"2008-01","completion":"2012-11","firstPosted":"2006-04-21","resultsPosted":"2013-03-25","lastUpdate":"2016-08-11"},"enrollment":104,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"SUPPORTIVE_CARE"},"conditions":["Colorectal Cancer","Neurotoxicity"],"interventions":[{"type":"DRUG","name":"calcium gluconate","otherNames":[]},{"type":"DRUG","name":"magnesium sulfate","otherNames":[]},{"type":"OTHER","name":"placebo","otherNames":[]}],"arms":[{"label":"Ca/Mg","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"RATIONALE: Calcium gluconate and magnesium sulfate may prevent or lessen neurotoxicity caused by oxaliplatin. It is not yet known whether calcium gluconate and magnesium sulfate are more effective than a placebo in preventing neurotoxicity caused by oxaliplatin in patients receiving combination chemotherapy.\n\nPURPOSE: This randomized phase III trial is studying calcium gluconate and magnesium sulfate to see how well they work compared to a placebo in preventing neurotoxicity caused by oxaliplatin in patients receiving combination chemotherapy for stage II, stage III, or stage IV colorectal cancer that has been completely removed by surgery.","primaryOutcome":{"measure":"Percentage of Patients With Oxaliplatin-induced Grade 2+ Chronic Neuropathic Adverse Event","timeFrame":"127 days","effectByArm":[{"arm":"Ca/Mg","deltaMin":22,"sd":null},{"arm":"Placebo","deltaMin":41,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.038"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":14,"countries":["United States"]},"refs":{"pmids":["21189381","26282635"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":50},"commonTop":["Diarrhea","Nausea","Constipation","Vomiting","Neutrophil count decreased"]}}